MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)

CUSIP: 61559X104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Class A ordinary share, par value $0.0001 per share
Shares outstanding
71,754,637
Total 13F shares
36,470,008
Share change
+35,816,136
Total reported value
$190,106,000
Price per share
$5.25
Number of holders
22
Value change
+$182,848,000
Number of buys
22
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 61559X104?
CUSIP 61559X104 identifies MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Helix Holdings LLC
3/4/5
Former 10% Holder —
class O/S missing
3,215,000
 $192,569,820 — 05 Apr 2022
3/4/5
MARSHALL WACE, LLP
13F
Company
0.91%
653,872
 $7,258,000 — 31 Mar 2022
13F

Institutional Holders of MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX) as of Q2 2022

As of 30 Jun 2022, MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,470,008 shares. The largest 10 holders included BVF INC/IL, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, FMR LLC, TCG Crossover Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., RTW INVESTMENTS, LP, GREAT POINT PARTNERS LLC, and TANG CAPITAL MANAGEMENT LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
1
Q2 2022 holders
22
Holder diff
21
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .